Mono Pharmacare (NSE:MONOPHARMA) Retained Earnings : ₹0 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mono Pharmacare Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Mono Pharmacare's retained earnings for the quarter that ended in Sep. 2024 was ₹0 Mil.

Mono Pharmacare's quarterly retained earnings increased from Sep. 2023 (₹0 Mil) to Mar. 2024 (₹30 Mil) but then declined from Mar. 2024 (₹30 Mil) to Sep. 2024 (₹0 Mil).

Mono Pharmacare's annual retained earnings increased from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹5 Mil) and increased from Mar. 2023 (₹5 Mil) to Mar. 2024 (₹30 Mil).

Mono Pharmacare Retained Earnings Historical Data

The historical data trend for Mono Pharmacare's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mono Pharmacare Retained Earnings Chart

Mono Pharmacare Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Retained Earnings

5.35

29.65

Mono Pharmacare Semi-Annual Data
	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Retained Earnings	Get a 7-Day Free Trial			-	5.35	-	29.65	-

Mono Pharmacare Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Mono Pharmacare (NSE:MONOPHARMA) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Mono Pharmacare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mono Pharmacare Ltd (NSE:MONOPHARMA) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

1A, Krinkal Apartment, Opp. Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007

Website

https://www.monopharmacareltd.com

Mono Pharmacare Ltd is a distributor and supplier of a wide array of Pharmaceuticals products and medicines. The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac-Diabetic medicines, and cosmocare products.

Mono Pharmacare Headlines

No Headlines